Nonetheless, the presence of higher levels of CD8+ in the tumor microenvironment could be an index of a patient’s better immune response, and, consequently, of the higher PD-L1 expression, indicating the higher intrinsic immune escape capability of the tumor [25]. The gene discussed is CD274; the disease is neoplasm.